Bexagliflozin is a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys, promoting urinary glucose excretion. It is used to improve glycemic control in patients with type 2 diabetes mellitus.

Bexagliflozin API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.